WallStreetZenWallStreetZen

NASDAQ: AKRO
Akero Therapeutics Inc Stock Ownership - Who owns Akero Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Akero Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jonathan YoungChief Operating Officer2024-04-014,600$24.33
$111.90kSell
Jonathan YoungChief Operating Officer2024-04-01400$25.03
$10.01kSell
Timothy RolphChief Scientific Officer2024-03-13619$28.33
$17.54kSell
Catriona YaleChief Development Officer2024-03-13723$28.33
$20.48kSell
Jonathan YoungChief Operating Officer2024-03-13651$28.33
$18.44kSell
William Richard WhiteChief Financial Officer2024-03-13724$28.33
$20.51kSell
Andrew ChengPresident and CEO2024-03-131,969$28.33
$55.78kSell
Catriona YaleChief Development Officer2024-03-0420,646$35.49
$732.73kSell
Andrew ChengPresident and CEO2024-03-0417,267$21.10
$364.33kBuy
Andrew ChengPresident and CEO2024-03-046,770$32.28
$218.54kSell

1 of 11

AKRO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKRO insiders and whales buy or sell their stock.

AKRO Shareholders

What type of owners hold Akero Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Versant Venture Capital Vi LP11.99%6,749,283$140.12MInsider
Apple Tree Partners Iv LP10.36%5,830,203$121.04MInsider
State Street Corp9.10%5,122,895$106.35MInstitution
Janus Henderson Group PLC7.65%4,306,401$89.40MInstitution
Blackrock Inc7.43%4,180,507$86.79MInstitution
Aaron Royston7.02%3,954,858$82.10MInsider
Alkeon Capital Management LLC6.69%3,764,220$78.15MInstitution
Price T Rowe Associates Inc6.53%3,675,924$76.31MInstitution
Rtw Investments LP6.38%3,592,759$74.59MInstitution
Trust Skorpios5.81%3,271,829$67.92MInsider

1 of 3

AKRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKRO66.82%33.18%Net BuyingNet Buying
ABCL40.68%47.55%Net BuyingNet Buying
PRTA53.06%46.94%Net BuyingNet Buying
SYRE55.87%44.13%Net BuyingNet Buying
MIRM48.94%51.06%Net BuyingNet Selling
View Top Biotech Stocks

Akero Therapeutics Stock Ownership FAQ

Who owns Akero Therapeutics?

Akero Therapeutics (NASDAQ: AKRO) is owned by 104.79% institutional shareholders, 52.03% Akero Therapeutics insiders, and 0.00% retail investors. Versant Venture Capital Vi LP is the largest individual Akero Therapeutics shareholder, owning 6.75M shares representing 11.99% of the company. Versant Venture Capital Vi LP's Akero Therapeutics shares are currently valued at $140.32M.

If you're new to stock investing, here's how to buy Akero Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.